CD8A and cancer: In addition, the interlink between the expression of PD-1 on Treg cells was observed as a negative regulator, highlighting that PD-1 blockade therapy may not only recover dysfunctional CD8+ T cells, but also enhances the suppressive function of T cells in cancer (54, 55).